Futura Strikes Deal To Commercialize Erectile Dysfunction Gel In Middle East
UK R&D firm Futura Medical strikes third commercial agreement for its drug-free erectile dysfunction treatment MED3000, this time with Switzerland’s Labatec Pharma, which will take the drug-free gel to the Middle East.
You may also be interested in...
The latest appointments in Europe's consumer health industry: Former Perrigo exec Jeff Needham joins Futura Medical; Bayer promotes Gomez to lead Swiss Consumer business; and Maxwellia appoints Al-Attbi to newly-created role.
Sleep might seem like a consumer healthcare category with limited potential for innovation. But with new herbal remedies, foods and dietary supplements coming on the UK market, regulatory expert Janet Worrell argues that there's still plenty of room for novelty.
Teva UK's first Rx-to-OTC switch is a UK Viagra Connect sildenafil competitor under the Liberize brand. Priced around 25% lower than the market leader, Teva's new brand must also compete with Perrigo's white label and Dr Reddy's Almus branded alternatives within the country's growing erectile dysfunction category.